ARGX: argenx SE Growth-Adjusted Market Cap to Net Income
argenx SE relies on hybrid manufacturing via Western CMO partners to ensure supply stability. The peg_co multiple on GURU.Markets reflects the balance between price and earnings, with the current figure standing at 0.75. A team of elite immunologists is attracted by the freedom of research, yet the business remains dependent on a single drug while expanding its application across various pathologies.
Metric breakdowns and analytics for argenx SE (ARGX)
- share price and consensus valuation forecast:
- market capitalization information:
- company book value details:
- issuer credit burden and liquidity indicators:
- business earnings and investment ratios data:
ARGX - Net Profit|Projected Net Profit argenx SE|ARGX - P/E Multiple|Projected Price to Earnings Ratio argenx BVBA|ARGX - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Argenx|ARGX - Operating profit before deduction of amortization|Earnings per share for the last 12 months argenx|ARGX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months argenx.com|ARGX - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year argenx SE
General company analysis:ARGX - argenx N.V.
The PEG ratio compares a stock's market value with its earnings growth rate, allowing for the determination of an asset's undervaluation relative to its expansion. By analyzing the P/E ratio against EPS dynamics, investors identify high-growth "rockets," which is critical for argenx SE (ARGX), where the robotization of antibody synthesis accelerates development, yet prolonged clinical trials create a time lag in monetization.
Competing companies
BNTX (BioNTech Inc.) - Growth-Adjusted Payback Ratio|PEG Multiple ABVX (abivax.com)|Growth-Adjusted Market Cap to Net Income ADMA Corp (ADMA)|PTGX - Price/Earnings to Growth Ratio|immunovant.com (IMVT) - Price/Earnings to Growth Multiple|Kiniksa (KNSA) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Grifols SA|Price/Earnings to Growth Multiple ADPT|PEG Multiple Celldex Corp|Price/Earnings to Growth Ratio Aurinia Pharmaceuticals (AUPH)|biocryst.com - Growth-Adjusted P/E Ratio|PEG Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Price to Earnings Adjusted for Growth Rate|Pharvaris Corp - PEG Multiple|ABCL - PEG Multiple|Tourmaline Bio, Inc. (TRML) - Price/Earnings to Growth Ratio|precigen.com - Growth-Adjusted Payback Ratio|PHAR (Pharming Group) - PEG Multiple|NKTR - Price to Net Income Growth Ratio|PEG Multiple UPB|ZBIO - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Immunome, Inc. IMNM|GOSS: Growth-Adjusted P/E Ratio|KALV: Price/Earnings to Growth Multiple|SEPN (Septerna, Inc.) - Growth-Adjusted P/E Ratio|PVLA (Pieris Pharmaceuticals Inc) - Price/Earnings to Growth Multiple|Savara Pharma - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Rigel Pharmaceuticals|anaptysbio.com (ANAB) - Growth-Adjusted Market Cap to Net Income|PEG Multiple ATXS|ENGN - Price to Earnings Adjusted for Growth Rate|PEG Multiple RAPT (RAPT Therapeutics, Inc.)|PEG Multiple Aerovate Therapeutics, Inc. JBIO|ACRS - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio KYTX (kyvernatx.com)|TLSA: PEG Multiple|Price to Net Income Growth Ratio Cabaletta Bio Inc. CABA|Price/Earnings to Growth Multiple VTYX|Growth-Adjusted P/E Ratio THTX (Theratechnologies, Inc)|Price/Earnings to Growth Ratio Avalo Therapeutics, Inc (AVTX)|ELDN: Market Cap to Earnings and Growth Ratio|PEG Multiple AGEN (Agenus Inc.)|Growth-Adjusted Payback Ratio CLYM|Zura Bio Limited - PEG Multiple|ATYR - PEG Multiple|adagene.com (ADAG) - Price/Earnings to Growth Ratio|Ikena Oncology - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Shattuck Labs Inc|Price/Earnings to Growth Multiple Equillium Bio (EQ)|PEG Multiple CNTB|PEG Multiple immunic-therapeutics.com (IMUX)|Atara Bio - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio IFRX|X4 Pharmaceuticals, Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Adicet Bio ACET|celularity.com (CELU) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple INmune Bio Corporation|Price/Earnings to Growth Ratio Barinthus Biotherapeutics|Price/Earnings to Growth Multiple kezarlifesciences.com (KZR)|Price/Earnings to Growth Multiple SABS (SAB Biotherapeutics, Inc.)|PEG Multiple Akari Therapeutics PLC (AKTX)|Price/Earnings to Growth Ratio Enlivex Therapeutics Ltd. ENLV|QTTB: Growth-Adjusted P/E Ratio|GeoVax Labs, Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate edesabiotech.com|IBIO: PEG Multiple|Carisma Therapeutics Inc. (CARM) - PEG Multiple|Price/Earnings to Growth Ratio XTL Biopharmaceuticals, Ltd.|BOLT: Growth-Adjusted Payback Ratio|PEG Multiple HCWB|aptevotherapeutics.com (APVO) - Price to Net Income Growth Ratio|PEG Multiple AIM (AIM ImmunoTech)|Aditxt Inc. (ADTX) - Price to Earnings Adjusted for Growth Rate|GRI - Price/Earnings to Growth Ratio|XRTX (XORTX Corp) - Growth-Adjusted P/E Ratio|HIND (Vyome Holdings Inc) - Price/Earnings to Growth Multiple|Growth-Adjusted P/E Ratio REVB|Price/Earnings to Growth Multiple INDP|SCNI: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio CalciMedica, Inc. (CALI)|Growth-Adjusted Market Cap to Net Income affimed.com|PEG Multiple ALLK (Allakos)|HOOKIPA Pharma, Inc. (HOOK) - Price to Earnings Adjusted for Growth Rate|IGM Bio - PEG Multiple|ITOS - PEG Multiple|Ocean Bio (OCEA) - Price/Earnings to Growth Ratio|TC BioPharm Ltd - Growth-Adjusted Payback Ratio|THRD (Third Harmonic Bio) - PEG Multiple
